![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIF26B |
Gene summary for KIF26B |
![]() |
Gene information | Species | Human | Gene symbol | KIF26B | Gene ID | 55083 |
Gene name | kinesin family member 26B | |
Gene Alias | KIF26B | |
Cytomap | 1q44 | |
Gene Type | protein-coding | GO ID | GO:0001655 | UniProtAcc | Q2KJY2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55083 | KIF26B | HTA11_347_2000001011 | Human | Colorectum | AD | 2.00e-04 | 1.66e-01 | -0.1954 |
55083 | KIF26B | HTA11_866_3004761011 | Human | Colorectum | AD | 4.21e-14 | 5.98e-01 | 0.096 |
55083 | KIF26B | HTA11_6818_2000001011 | Human | Colorectum | AD | 2.00e-05 | 4.28e-01 | 0.0112 |
55083 | KIF26B | HTA11_6818_2000001021 | Human | Colorectum | AD | 7.50e-18 | 8.63e-01 | 0.0588 |
55083 | KIF26B | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.59e-04 | 1.98e-01 | 0.294 |
55083 | KIF26B | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.15e-07 | 2.97e-01 | 0.3859 |
55083 | KIF26B | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.17e-06 | 2.26e-01 | 0.3005 |
55083 | KIF26B | A001-C-007 | Human | Colorectum | CRC | 5.42e-09 | 6.37e-01 | 0.1899 |
55083 | KIF26B | AEH-subject1 | Human | Endometrium | AEH | 7.61e-13 | 3.96e-01 | -0.3059 |
55083 | KIF26B | AEH-subject2 | Human | Endometrium | AEH | 1.49e-08 | 3.68e-01 | -0.2525 |
55083 | KIF26B | AEH-subject4 | Human | Endometrium | AEH | 7.13e-09 | 4.20e-01 | -0.2657 |
55083 | KIF26B | EEC-subject1 | Human | Endometrium | EEC | 7.32e-16 | 5.46e-01 | -0.2682 |
55083 | KIF26B | EEC-subject2 | Human | Endometrium | EEC | 4.31e-10 | 4.07e-01 | -0.2607 |
55083 | KIF26B | EEC-subject3 | Human | Endometrium | EEC | 3.77e-14 | 5.37e-01 | -0.2525 |
55083 | KIF26B | EEC-subject4 | Human | Endometrium | EEC | 2.44e-05 | 2.74e-01 | -0.2571 |
55083 | KIF26B | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 4.23e-03 | 8.97e-02 | -0.1869 |
55083 | KIF26B | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 2.77e-02 | 9.42e-02 | -0.1875 |
55083 | KIF26B | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 2.84e-04 | 7.33e-02 | -0.1883 |
55083 | KIF26B | HCC2_Meng | Human | Liver | HCC | 3.57e-03 | 7.12e-02 | 0.0107 |
55083 | KIF26B | S014 | Human | Liver | HCC | 2.32e-34 | 1.11e+00 | 0.2254 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007163 | Colorectum | AD | establishment or maintenance of cell polarity | 77/3918 | 218/18723 | 5.72e-07 | 2.08e-05 | 77 |
GO:0030010 | Colorectum | AD | establishment of cell polarity | 50/3918 | 143/18723 | 6.90e-05 | 1.11e-03 | 50 |
GO:0045785 | Colorectum | AD | positive regulation of cell adhesion | 122/3918 | 437/18723 | 2.65e-04 | 3.28e-03 | 122 |
GO:0060562 | Colorectum | AD | epithelial tube morphogenesis | 93/3918 | 325/18723 | 5.65e-04 | 6.00e-03 | 93 |
GO:0072073 | Colorectum | AD | kidney epithelium development | 42/3918 | 136/18723 | 4.02e-03 | 2.80e-02 | 42 |
GO:0060560 | Colorectum | AD | developmental growth involved in morphogenesis | 66/3918 | 234/18723 | 4.75e-03 | 3.22e-02 | 66 |
GO:00071632 | Colorectum | MSS | establishment or maintenance of cell polarity | 72/3467 | 218/18723 | 1.90e-07 | 8.30e-06 | 72 |
GO:00300102 | Colorectum | MSS | establishment of cell polarity | 47/3467 | 143/18723 | 2.74e-05 | 5.58e-04 | 47 |
GO:00605621 | Colorectum | MSS | epithelial tube morphogenesis | 88/3467 | 325/18723 | 8.45e-05 | 1.37e-03 | 88 |
GO:00457852 | Colorectum | MSS | positive regulation of cell adhesion | 110/3467 | 437/18723 | 2.94e-04 | 3.87e-03 | 110 |
GO:00605601 | Colorectum | MSS | developmental growth involved in morphogenesis | 61/3467 | 234/18723 | 2.56e-03 | 2.03e-02 | 61 |
GO:00720731 | Colorectum | MSS | kidney epithelium development | 38/3467 | 136/18723 | 4.53e-03 | 3.19e-02 | 38 |
GO:0001655 | Colorectum | MSS | urogenital system development | 81/3467 | 338/18723 | 6.88e-03 | 4.43e-02 | 81 |
GO:00071634 | Colorectum | CRC | establishment or maintenance of cell polarity | 57/2078 | 218/18723 | 3.96e-10 | 1.58e-07 | 57 |
GO:00300104 | Colorectum | CRC | establishment of cell polarity | 40/2078 | 143/18723 | 2.09e-08 | 3.23e-06 | 40 |
GO:00605603 | Colorectum | CRC | developmental growth involved in morphogenesis | 53/2078 | 234/18723 | 2.88e-07 | 2.54e-05 | 53 |
GO:00457855 | Colorectum | CRC | positive regulation of cell adhesion | 81/2078 | 437/18723 | 2.28e-06 | 1.10e-04 | 81 |
GO:00720733 | Colorectum | CRC | kidney epithelium development | 34/2078 | 136/18723 | 3.87e-06 | 1.63e-04 | 34 |
GO:00016552 | Colorectum | CRC | urogenital system development | 62/2078 | 338/18723 | 4.67e-05 | 1.10e-03 | 62 |
GO:00720011 | Colorectum | CRC | renal system development | 56/2078 | 302/18723 | 7.85e-05 | 1.63e-03 | 56 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa048144 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa0481411 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa048142 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
hsa048143 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIF26B | SNV | Missense_Mutation | c.3436N>T | p.Gly1146Trp | p.G1146W | Q2KJY2 | protein_coding | deleterious(0) | benign(0.41) | TCGA-CD-8536-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | epirubicin | CR | |
KIF26B | SNV | Missense_Mutation | c.3614G>A | p.Gly1205Asp | p.G1205D | Q2KJY2 | protein_coding | deleterious(0) | possibly_damaging(0.661) | TCGA-CG-5723-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
KIF26B | SNV | Missense_Mutation | c.2285G>T | p.Arg762Leu | p.R762L | Q2KJY2 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-FP-A4BE-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | |
KIF26B | SNV | Missense_Mutation | novel | c.5977N>A | p.Glu1993Lys | p.E1993K | Q2KJY2 | protein_coding | deleterious(0.02) | probably_damaging(0.994) | TCGA-HF-7131-01 | Stomach | stomach adenocarcinoma | Female | Unknown | I/II | Unspecific | Fluorouracil | SD |
KIF26B | SNV | Missense_Mutation | c.1528N>A | p.Asp510Asn | p.D510N | Q2KJY2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-HU-A4G8-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD | |
KIF26B | SNV | Missense_Mutation | rs780936718 | c.3515C>T | p.Thr1172Met | p.T1172M | Q2KJY2 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-HU-A4GN-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | mitomycin | PD |
KIF26B | SNV | Missense_Mutation | c.2570N>A | p.Ser857Asn | p.S857N | Q2KJY2 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-HU-A4GX-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | taxol | SD | |
KIF26B | SNV | Missense_Mutation | novel | c.4357N>A | p.Ala1453Thr | p.A1453T | Q2KJY2 | protein_coding | tolerated(0.17) | benign(0) | TCGA-MX-A5UJ-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
KIF26B | SNV | Missense_Mutation | c.1210N>T | p.Arg404Trp | p.R404W | Q2KJY2 | protein_coding | deleterious(0.02) | probably_damaging(0.944) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | ||
KIF26B | SNV | Missense_Mutation | novel | c.6032N>T | p.Ala2011Val | p.A2011V | Q2KJY2 | protein_coding | tolerated(0.76) | benign(0) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |